A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia

CompletedOBSERVATIONAL

Enrollment

287

Participants

Timeline

Start Date

August 29, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions

Metastatic Urothelial Cancer

Interventions

OTHER

No intervention

No investigational drug will be administered to participants in this study.

Trial Locations (1)

KR00001, Seoul

All Listed Sponsors

lead

Astellas Pharma Singapore Pte. Ltd.

INDUSTRY

NCT06505746 - A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia | Biotech Hunter | Biotech Hunter